keyboard_arrow_up

Global Testosterone Therapy Market 2018 Opportunities & Trends

MarketReportsOnline.com adds "Global Testosterone Therapy Market: Trends and Opportunities (2013-2018)" report to its research store.

Testosterone Therapy is a process of giving testosterone when the human body does not produce sufficient amount of testosterone because of old age, injury, damage or absence. Male hypogonadism means the testicles don't produce enough of the male sex hormone testosterone; this is when testosterone replacement therapy (TRT) is used as a solution. TRT has gained momentum in the last decade with increase in the number of cases of hypogonadism.

The sales of testosterone products have increased globally and it is expected to increase even further in coming years. The U.S is the main market for TRT with the highest penetration rate and characterized by the presence of all the major market players including AbbVie, Eli Lilly, Auxillium Pharmaceuticals and Actavis. Low penetration rate of testosterone replacement therapy in the geographical regions of Europe and Asia-Pacific is because of the fact that this is a lesser known technology. But nevertheless, low penetration and higher need for this treatment results in a largely untapped market that needs strong promotional activities and awareness programs.

Company Coverage: AbbVie Inc, Actavis Inc, Eli Lilly & Co and Auxilium Pharmaceuticals Inc

Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=295936.

New Products such as Axiron, AndroGel 1.62% and Foresta, which were introduced recently in the market are slowly replacing old brands and are gaining market share. Gels are becoming the dominant segment of testosterone deficiency treatment and are replacing injectables, orals and patches segments.

The report titled "Global Testosterone Therapy Market": Trends & Opportunities (2013-2018)" provides an in-depth analysis of the Global Testosterone Therapy Market with detailed analysis of symptoms, diagnosis and treatment of testosterone deficiency. The report majorly focuses on the US testosterone therapy market and also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall testosterone therapy industry has also been forecasted for the period 2013-2018, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like AbbVie Inc, Actavis Inc, Eli Lilly & Co. and Auxilium Pharmaceuticals Inc are profiled.

Major points from Table of Contents (http://www.marketreportsonline.com/295936-toc.html) are listed below:

List of Figures

Figure 1: Main Symptoms of Testosterone Deficiency

Figure 2: Percentage of Testosterone Deficient According to Age Distribution

Figure 3: Benefits of Testosterone Therapy

Figure 4: Side Effects of Testosterone Therapy

Figure 5: Global Testosterone Market Sales: 2005 to 2012 (US$ Million)

Figure 6: Global Testosterone Market Sales Forecast: 2013 to 2018 (US$ Million)

Figure 7: Market Share of Testosterone Products: 2011 to 2013

Figure 8: Global Testosterone Replacement Therapy Treatment Penetration Rate as of 2012

Figure 9: Distribution of Testosterone Therapy Options by Country as of 2011

Figure 10: Global Market Size of Hypogonadism: 2010 to 2012 (US$ Billion)

Figure 11: Global Market Size of Hypogonadism Forecasted: 2013 to 2018 (US$ Billion)

Related Reports on Pharmaceuticals Market:

The US Pharmacy Benefit Management (PBM) Industry Report: 2013 Edition (http://www.marketreportsonline.com/315005.html) In the US, a third party administrator of prescription drug program is known as a Pharmacy Benefit Manager (PBM). The primary responsibilities of a PBM include processing and paying prescriptions drug claim, developing and maintaining formulary, negotiating discounts and rebates with drug manufacturers and pharmacies. The US prescription volume has witnessed an unprecedented growth over the past few years and the same pattern is likely to continue in the near future. Therefore, through rebates from pharmaceutical manufacturers, price discounts from retails, and effective mail service pharmacies, the PBMs ceaselessly focus on enabling the plan sponsors and individuals to obtain prescribed drugs at lower prices.

Global IV Iron Drugs Market Report: 2014 Edition (http://www.marketreportsonline.com/341239.html) Intravenous (IV) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. Also, this method ensures 100% bioavailability, which means that the chemicals delivered are fully absorbed by the body.

About Us:

MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and  offline support to our customers. Get in touch with us for your needs of market research reports.

Contact:

Ritesh Tiwari

Corporate Office

TX, Dallas North - Dominion Plaza,

17304, Preston Road,

Suite 800, Dallas 75252.

Tel: + 1 888 391 5441

E-mail: sales@marketreportsonline.com